by According to Precedence Research, during the forecast period of 2022 to 2030, the global vitamin C market is estimated to develop at a compound annual growth rate (CAGR) of 6.32%. The global vitamin C market was valued at USD 1.55 billion in 2021, and it is predicted to exceed USD 15.7 billion by 2030. The study investigates several elements and their consequences on the growth of the vitamin C market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1842
This report focuses on vitamin C market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall vitamin C market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Vitamin C Market
| Report Coverage | Details |
| Market Size by 2030 | USD 15.7 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.32% |
| Pharmaceuticals Application Segment Share in 2021 | 20% |
| North American Market Share in 2021 | 48% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Source, Process, Application, Form, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of vitamin C, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of vitamin C has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the vitamin C market.
Some of the prominent players in the vitamin C market include:
- Beijing Heronsbill Food Material Co.,Ltd (China)
- Duchefa Biochemie (Netherland)
- Medibro Corporation Limited (China)
- ADM (US)
- Sanofi (France)
- Bayer AG (Germany) Chemizo Enterprise (India)
- Foodchem International Corporation (China)
- Mudanjiang High-Tech Biochemical Co. Ltd. (China)
- Amway India Enterprises Pvt. Ltd (India)
- CSPC Pharmaceutical Group Limited (China)
- Glanbia plc (Ireland)
- Northeast Pharmaceutical Group Co.,Ltd. (China)
- The TNN Development Limited (China)
- Microbelcaps (Belgium)
- DSM (Netherlands)
- DuPont (US)
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1842
Segments Covered in the Report
By Type
- Calcium Ascorbate
- Sodium Ascorbate
- Magnesium Ascorbate
- Coated Vitamin C
- Potassium Ascorbate
- D-Isoascorbic Acid
- Ascorbic Acid
- Others
By Source
- Natural
- Synthetic
By Process
- Two-stage Fermentation Process
- Reichstein Process
By Application
- Food and Beverages
- Pharmaceutical
- Cosmetics
- Animal feed
By Form
- Tablet
- Syrups
- Injections
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Vitamin C Market
5.1. COVID-19 Landscape: Vitamin C Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Vitamin C Market, By Type
8.1. Vitamin C Market, by Type, 2022-2030
8.1.1. Calcium Ascorbate
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Sodium Ascorbate
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Magnesium Ascorbate
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Coated Vitamin C
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Potassium Ascorbate
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. D-Isoascorbic Acid
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Ascorbic Acid
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Vitamin C Market, By Source
9.1. Vitamin C Market, by Source, 2022-2030
9.1.1. Natural
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Synthetic
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Vitamin C Market, By Process
10.1. Vitamin C Market, by Process, 2022-2030
10.1.1. Two-stage Fermentation Process
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Reichstein Process
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Vitamin C Market, By Application
11.1. Vitamin C Market, by Application, 2022-2030
11.1.1. Food and Beverages
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceutical
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Cosmetics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Animal feed
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Vitamin C Market, By Form
12.1. Vitamin C Market, by Form, 2022-2030
12.1.1. Tablet
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Syrups
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Injections
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Vitamin C Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Source (2017-2030)
13.1.3. Market Revenue and Forecast, by Process (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by Form (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Process (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.7. Market Revenue and Forecast, by Form (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Process (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Form (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.3. Market Revenue and Forecast, by Process (2017-2030)
13.2.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.5. Market Revenue and Forecast, by Form (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Process (2017-2030)
13.2.7. Market Revenue and Forecast, by Application (2017-2030)
13.2.8. Market Revenue and Forecast, by Form (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Process (2017-2030)
13.2.10. Market Revenue and Forecast, by Application (2017-2030)
13.2.11. Market Revenue and Forecast, by Form (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Process (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.13. Market Revenue and Forecast, by Form (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Source (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Process (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.15. Market Revenue and Forecast, by Form (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.3. Market Revenue and Forecast, by Process (2017-2030)
13.3.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.5. Market Revenue and Forecast, by Form (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Process (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.7. Market Revenue and Forecast, by Form (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Process (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.9. Market Revenue and Forecast, by Form (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Process (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Form (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Source (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Process (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.5. Market Revenue and Forecast, by Form (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.3. Market Revenue and Forecast, by Process (2017-2030)
13.4.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.5. Market Revenue and Forecast, by Form (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Process (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.7. Market Revenue and Forecast, by Form (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Process (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.9. Market Revenue and Forecast, by Form (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Process (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Form (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Source (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Process (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.5. Market Revenue and Forecast, by Form (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Source (2017-2030)
13.5.3. Market Revenue and Forecast, by Process (2017-2030)
13.5.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.5. Market Revenue and Forecast, by Form (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Source (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Process (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.7. Market Revenue and Forecast, by Form (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Source (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Process (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Form (2017-2030)
Chapter 14. Company Profiles
14.1. Beijing Heronsbill Food Material Co.,Ltd
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Duchefa Biochemie
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Medibro Corporation Limited
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ADM
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Sanofi
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bayer AG (Germany) Chemizo Enterprise
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Foodchem International Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Mudanjiang High-Tech Biochemical Co. Ltd.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Amway India Enterprises Pvt. Ltd
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. CSPC Pharmaceutical Group Limited
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1842
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
